ALONSO ABAD, Ariel

Email Alert RSS Feed

Profile

Full Name
ALONSO ABAD, Ariel
Email
ariel.alonsoabad@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 1-33 of 78 (Search time: 0.047 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
12024An information‐theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluationALONSO ABAD, Ariel; ONG, Fenny; Stijven, Florian; VAN DER ELST, Wim; MOLENBERGHS, Geert; VAN KEILEGOM, Ingrid; VERBEKE, Geert; Callegaro, AndreaJournal ContributionA1
22023A multivariate spatio-temporal model for the incidence of imported COVID-19 cases and COVID-19 deaths in CubaDe Witte , Dries; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; VERBEKE, Geert; SANCHEZ, Lizet; Mas-Bermejo, Pedro; NEYENS, ThomasJournal ContributionA1
32022Implementing the meta-analytic approach for the evaluation of surrogate endpoints in SAS and R: a word of cautionONG, Fenny; Wang, Jingzhao; VAN DER ELST, Wim; VERBEKE, Geert; MOLENBERGHS, Geert; ALONSO ABAD, ArielJournal ContributionA1
42022Identifying individual predictive factors for treatment efficacyALONSO ABAD, Ariel; VAN DER ELST, Wim; SANCHEZ, Lizet; Luaces, Patricia; MOLENBERGHS, GeertJournal ContributionA1
52021Evaluation of surrogate endpointsMOLENBERGHS, Geert; SHKEDY, Ziv; BURZYKOWSKI, Tomasz; BUYSE, Marc; ALONSO ABAD, Ariel; VAN DER ELST, WimBook SectionB2
62021The individual-level surrogate threshold effect in a causal-inference setting with normally distributed endpointsVAN DER ELST, Wim; ALONSO ABAD, Ariel; Coppenolle, Hans; MEYVISCH, Paul; MOLENBERGHS, GeertJournal ContributionA1
72020Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patientsLorenzo-Luaces, Patricia; SANCHEZ, Lizet; Saavedra, Danay; Crombet, Tania; VAN DER ELST, Wim; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; Lage, AgustinJournal ContributionA1
82020On the relationship between association and surrogacy when both the surrogate and true endpoint are binary outcomesMEYVISCH, Paul; ALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, GeertJournal ContributionA1
92020Meta-analytic approach to evaluation of surrogate endpointsBURZYKOWSKI, Tomasz; BUYSE, Marc; MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; SHKEDY, ZivBook SectionB2
102020Generating random correlation matrices with fixed values: An application to the evaluation of multivariate surrogate endpointsFLOREZ POVEDA, Alvaro; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; VAN DER ELST, WimJournal ContributionA1
112019A reflection on the possibility of finding a good surrogateALONSO ABAD, Ariel; MEYVISCH, Paul; VAN DER ELST, Wim; MOLENBERGHS, Geert; VERBEKE, GeertJournal ContributionA1
122019A reflection on the causal interpretation of individual-level surrogacyALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; Florez, Alvaro J.Journal ContributionA1
132018PREDICTIVE BIOMARKERS OF TREATMENT SUCCESS IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS USING MULTIVARIATE CAUSAL INFERENCE.Lorenzo-Luaces, P.; Saavedra, D.; VAN DER ELST, Wim; ALONSO ABAD, Ariel; Viada Gonzalez, C.; SANCHEZ, LizetJournal ContributionM
142018A maximum entropy approach for the evaluation of surrogate endpoints based on causal inferenceALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, GeertJournal ContributionA1
152018Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trialMEYVISCH, Paul; Kambili, Chrispin; Andries, Koen; Lounis, Nacer; Theeuwes, Myriam; Dannemann, Brian; Vandebosch, An; VAN DER ELST, Wim; MOLENBERGHS, Geert; ALONSO ABAD, ArielJournal ContributionA1
162018Statistical evaluation of surrogate endpoints in cancer clinical trialsBUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, K.; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, TomaszBook SectionB2
172017The R Package SurrogateVAN DER ELST, Wim; ALONSO ABAD, Ariel; MOLENBERGHS, GeertBook SectionB2
182017Applied Surrogate Endpoint Evaluation Methods with SAS and RALONSO ABAD, Ariel; BIGIRUMURAME, Theophile; BURZYKOWSKI, Tomasz; BUYSE, Marc; MOLENBERGHS, Geert; MUCHENE, Leacky; PERUALILA, Nolen Joy; SHKEDY, Ziv; VAN DER ELST, WimBookB1
192016Statistical evaluation of surrogate endpoints with examples from cancer clinical trialsBUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, Koji; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, TomaszJournal ContributionA1
202016Exploring the relationship between the causal-inference and meta-analytic paradigms for the evaluation of surrogate endpointsVAN DER ELST, Wim; MOLENBERGHS, Geert; ALONSO ABAD, ArielJournal ContributionA1
212015Estimation after a group sequential trialMILANZI, Elasma; MOLENBERGHS, Geert; ALONSO ABAD, Ariel; Kenward, M.G.; Tsiatis, A.A.; Davidian, M.; VERBEKE, GeertJournal ContributionA1
222015Reliability Measures In Item Response Theory: Manifest Versus Latent Correlation FunctionsMILANZI, Elasma; MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VERBEKE, Geert; De Boeck, PaulJournal ContributionA1
232015Validating predictors of therapeutic success: A causal inference approachALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, GeertJournal ContributionA1
242015Impact of selection bias on the evaluation of clusters of chemical compounds in the drug discovery process.MILANZI, Elasma; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; Buyck, Christophe; BIJNENS, LucJournal ContributionA1
252015A new modeling approach for quantifying expert opinion in the drug discovery processMILANZI, Elasma; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; Buyck, Christophe; BIJNENS, LucJournal ContributionA1
262015On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpointsALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
272015Biomarker‑based surrogate endpointsBUYSE, Marc; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; ALONSO ABAD, ArielBook SectionB2
282014Estimation After a Group Sequential TrialMILANZI, Elasma; MOLENBERGHS, Geert; ALONSO ABAD, Ariel; Kenward, Michael G; Tsiatis, Anastasios A; Davidian, Marie; VERBEKE, GeertWorking PaperR2
292014Impact of selection bias on the evaluation of clusters of chemical compounds in the drug discovery processALONSO ABAD, Ariel; MILANZI, Elasma; MOLENBERGHS, Geert; Buyck, Christophe; BIJNENS, LucWorking PaperR2
302014Statistical Validation of Surrogate Markers in Clinical TrialsALONSO ABAD, Ariel; MOLENBERGHS, Geert; Van Breukelen, GerardBook SectionB2
312014A permutational-splitting sample procedure to quantify expert opinion on clusters of chemical compounds using high-dimensional dataMILANZI, Elasma; ALONSO ABAD, Ariel; Buyck, Christophe; MOLENBERGHS, Geert; BIJNENS, LucJournal ContributionA1
322013Review: Clinical Trial Methodology: Surrogate endpoints: when should they be used?MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
332013Statistical evaluation of surrogate endpoints in clinical studiesMOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz; BUYSE, MarcBook SectionB2
show all